Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
International Stem Cell Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ISCO
Over the counter
8731
http://www.internationalstemcell.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for International Stem Cell Corp
International Stem Cell Corporation to Present Interim Clinical Results at the American Academy of Neurology
- Apr 18th, 2018 6:30 am
International Stem Cell Corporation Announces 2017 Fourth Quarter and Year-End Results
- Apr 10th, 2018 6:45 am
International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson's Disease Clinical Trial
- Mar 5th, 2018 6:30 am
Edison Issues Update On International Stem Cell (ISCO)
- Jan 22nd, 2018 8:22 am
International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017
- Dec 27th, 2017 6:39 am
International Stem Cell Corp (ISCO) CEO Andrey Semechkin Bought $3.3 million of Shares
- Dec 8th, 2017 2:15 pm
International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial
- Nov 13th, 2017 6:30 am
International Stem Cell Corporation Receives Key Stem Cell Patent in Australia
- Oct 31st, 2017 7:00 am
International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases
- Oct 9th, 2017 6:30 am
International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
- Sep 18th, 2017 11:13 am
Scroll